Puma Biotechnology, Inc. (PBYI)
6.76
+0.37
(+5.79%)
USD |
NASDAQ |
Apr 01, 16:00
6.75
-0.01
(-0.15%)
After-Hours: 20:00
Puma Biotechnology Total Liabilities (Quarterly) : 87.33M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 169.14M |
| AbbVie, Inc. | 137.19B |
| Trevi Therapeutics, Inc. | 10.38M |
| Phathom Pharmaceuticals, Inc. | 697.97M |
| Terns Pharmaceuticals, Inc. | 18.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.67M |
| Shareholders Equity (Quarterly) | 130.34M |
| Debt to Equity Ratio | 0.219 |
| Current Ratio | 2.002 |
| Net Debt Paydown Yield | 3.86% |